Central retinal vein occlusion in patients treated with long-term warfarin sodium (Coumadin) for anticoagulation

Retina

Volumn 26, Issue 3, 2006, Pages 285-291

  Mruthyunjaya, Prithvi ^a   Wirostko, William J ^b   Chandrashekhar, Ravindra ^c   Stinnett, Sandra ^a   Lai, James C ^d,e   Deramo, Vincent ^d,e   Tang, Johnny ^e,f   Dev, Sundeep ^b,g   Postel, Eric A ^a   Connor, Thomas B ^b   Fekrat, Sharon ^a  

^a DUKE UNIVERSITY EYE CENTER   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c Wilson Memorial Regional Medical Center   (United States)

^d Long Island Vitreoretinal Consultants   (United States)

^e NORTH SHORE UNIVERSITY HOSPITAL   (United States)

^f NATIONAL EYE INSTITUTE   (United States)

^g VitreoRetinal Surgery   (United States)

Author keywords

Anticoagulation; Central retinal vein occlusion; Coumadin; International normalization ratio; Retinal vein occlusion; Systemic; Therapeutic

Indexed keywords

ALTEPLASE; ANTICOAGULANT AGENT; CYANOCOBALAMIN; FOLIC ACID; PENTOXIFYLLINE; TRIAMCINOLONE ACETONIDE; WARFARIN;

ADULT; AGED; ANTICOAGULATION; ARTICLE; CENTRAL RETINA VEIN OCCLUSION; CLINICAL ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; INTERNATIONAL NORMALIZED RATIO; MALE; PERFUSION; RETROSPECTIVE STUDY; THROMBOEMBOLISM; VISUAL ACUITY; VITREOUS HEMORRHAGE; BLOOD CLOTTING; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; DRUG EFFECT; EYE; MIDDLE AGED; PHYSIOLOGY; RETINA BLOOD VESSEL; RETINA VEIN OCCLUSION; THROMBOSIS; VASCULARIZATION;

AGED; AGED, 80 AND OVER; ANTICOAGULANTS; BLOOD COAGULATION; EYE; FEMALE; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; MIDDLE AGED; RETINAL VEIN OCCLUSION; RETINAL VESSELS; RETROSPECTIVE STUDIES; THROMBOSIS; VISUAL ACUITY; WARFARIN;

EID: 33646461756     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006982-200603000-00006     Document Type: Article

References (28)

1. Green WR, Chan CC, Hutchins GM, Terry JM. Central retinal vein occlusion: a prospective histopathologic study of 29 eyes in 28 cases. Trans Am Ophthalmol Soc 1981;79:371-422.
2. Hayreh SS. Central retinal vein occlusion. Ophthalmol Clin North Am 1998;11:559-590.
3. Anonymous. Risk factors for central retinal vein occlusion. The Eye Disease Case-Control Study Group. Arch Ophthalmol 1996;114:545-554.
4. Elman MJ, Bhatt AK, Quinlan PM, Enger C. The risk for systemic vascular diseases and mortality in patients with central retinal vein occlusion. Ophthalmology 1990;97:1543-15488.
5. Fekrat S, Finkelstein D. Venous occlusive disease. In: Regillo CD, Brown GC, Flynn HW, eds. Vitreoretinal Disease: The Essentials. 1st ed. New York: Thieme; 1999.
6. Lahey JM, Tunc M, Kearney J, et al. Laboratory evaluation of hypercoagulable states in patients with central retinal vein occlusion who are less than 56 years of age. Ophthalmology 2002;109:126-131.
7. De Sanctis MT, Cesarone MR, Belcaro G, et al. Treatment of retinal vein thrombosis with pentoxifylline: a controlled, randomized trial. Angiology 2002;53:S35-S38.
8. Elman MJ. Thrombolytic therapy for central retinal vein occlusion: results of a pilot study. Trans Am Ophthalmol Soc 1996;94:471-504.
9. Elman MJ, Raden RZ, Carrigan A. Intravitreal injection of tissue plasminogen activator for central retinal vein occlusion. Trans Am Ophthalmol Soc 2001;99:219-223.
10. Glacet-Bernard A, Coscas G, Chabanel A, et al. A randomized, double-masked study on the treatment of retinal vein occlusion with troxerutin. Am J Ophthalmol 1994;118:421-429.
11. Glacet-Bernard A, Kuhn D, Vine AK, et al. Treatment of recent onset central retinal vein occlusion with intravitreal tissue plasminogen activator: a pilot study. Br J Ophthalmol 2000;84:609-613.
12. Houtsmuller AJ, Vermeulen JA, Klompe M, et al. The influence of ticlopidine on the natural course of retinal vein occlusion. Agents Actions Suppl 1984;15:219-229.
13. Lahey JM, Fong DS, Kearney J. Intravitreal tissue plasminogen activator for acute central retinal vein occlusion. Ophthalmic Surg Lasers 1999;30:427-434.
14. Weiss JN. Treatment of central retinal vein occlusion by injection of tissue plasminogen activator into a retinal vein. Am J Ophthalmol 1998;126:142-144.
15. Weiss JN, Bynoe LA. Injection of tissue plasminogen activator into a branch retinal vein in eyes with central retinal vein occlusion. Ophthalmology 2001;108:2249-2257.
16. Hirsh J, Dalen J, Anderson DR, et al. Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest 2001;119:S8-S21.
17. Clarkson JG. Central Vein Occlusion Study: photographic protocol and early natural history. Trans Am Ophthalmol Soc 1994;92:203-215.
18. Mant M, Stand L, Etches W. Warfarin monitoring in patients with anticardiolipin antibodies, but without lupus anticoagulant. Thromb Res 2000;99:477-482.
19. Hayreh SS, Zimmerman B, McCarthy MJ, Podhajsky P. Systemic diseases associated with various types of retinal vein occlusion. Am J Ophthalmol 2001;131:61-77.
20. Klein R, Klein BE, Moss SE, Meuer SM. The epidemiology of retinal vein occlusion: the Beaver Dam Eye Study. Trans Am Ophthalmol Soc 2000;98:133-143.
21. Greaves M. Aging and the pathogenesis of retinal vein thrombosis. Br J Ophthalmol 1997;81:810-811.
22. Cahill MT, Stinnett SS, Fekrat S. Meta-analysis of plasma homocysteine, serum folate, serum vitamin B(12), and thermolabile MTHFR genotype as risk factors for retinal vascular occlusive disease. Am J Ophthalmol 2003;136:136-1150.
23. Abu El-Asrar AM, Abdel Gader AG, Al-Amro S, Al-Momen AK. Hypercoagulable states in patients with retinal venous occlusion. Doc Ophthalmol 1998;95:133-143.
24. Hayreh SS, Zimmerman MB, Podhajsky P. Hematologic abnormalities associated with various types of retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 2002;240:180-196.
25. Browning DJ, Fraser CM. Retinal vein occlusions in patients taking warfarin. Ophthalmology 2004;111:1196-1200.
26. Anonymous. Natural history and clinical management of central retinal vein occlusion. The Central Vein Occlusion Study Group. Arch Ophthalmol 1997;115:486-491.
27. Green W, Chan C, Hutchins G, Terry J. Central retinal vein occlusions: a prospective histopathologic study of 29 eyes in 28 cases. Retina 1981;1:27-55.
28. Shaikh S, Blumenkranz MS. Transient improvement in visual acuity and macular edema in central retinal vein occlusion accompanied by inflammatory features after pulse steroid and anti-inflammatory therapy. Retina 2001;21:176-178.